Difficulty: Medium
Average Score: 92%
Practice
Acetylcholine is not a specific neurotransmitter at:
Correct answer
B
Rationale
In the context of pharmacology across the lifespan, understanding the role of acetylcholine as a neurotransmitter is crucial. The correct answer to this question is B) Sympathetic postganglionic nerve endings.
Acetylcholine is a neurotransmitter that plays a key role in both the parasympathetic and sympathetic nervous systems. In the parasympathetic division, acetylcholine is the primary neurotransmitter at both ganglia and postganglionic nerve endings. However, in the sympathetic division, acetylcholine is not the primary neurotransmitter at postganglionic nerve endings. Instead, norepinephrine is the primary neurotransmitter at sympathetic postganglionic nerve endings.
This distinction is important in understanding the autonomic nervous system and how different neurotransmitters mediate responses in various parts of the body. By knowing that acetylcholine is not the specific neurotransmitter at sympathetic postganglionic nerve endings, healthcare providers can better understand the effects of sympathetic stimulation and the implications for pharmacological interventions targeting these pathways.
This knowledge is particularly relevant in pharmacology across the lifespan as it can help in understanding the effects of medications that target the autonomic nervous system, especially in conditions where sympathetic stimulation or inhibition is a therapeutic target. Understanding the specific roles of neurotransmitters like acetylcholine in different parts of the autonomic nervous system is essential for safe and effective medication management in patients of all ages.
Acetylcholine is a neurotransmitter that plays a key role in both the parasympathetic and sympathetic nervous systems. In the parasympathetic division, acetylcholine is the primary neurotransmitter at both ganglia and postganglionic nerve endings. However, in the sympathetic division, acetylcholine is not the primary neurotransmitter at postganglionic nerve endings. Instead, norepinephrine is the primary neurotransmitter at sympathetic postganglionic nerve endings.
This distinction is important in understanding the autonomic nervous system and how different neurotransmitters mediate responses in various parts of the body. By knowing that acetylcholine is not the specific neurotransmitter at sympathetic postganglionic nerve endings, healthcare providers can better understand the effects of sympathetic stimulation and the implications for pharmacological interventions targeting these pathways.
This knowledge is particularly relevant in pharmacology across the lifespan as it can help in understanding the effects of medications that target the autonomic nervous system, especially in conditions where sympathetic stimulation or inhibition is a therapeutic target. Understanding the specific roles of neurotransmitters like acetylcholine in different parts of the autonomic nervous system is essential for safe and effective medication management in patients of all ages.